Impact of COVID-19 on the Management of Early-Stage Breast Cancer - Episode 4

TAILORx Trial

February 9, 2021

Cancer Network Staff

EP. 1: Case Overview: Early-Stage Breast Cancer During COVID-19

EP. 2: Management of Early-Stage Breast Cancer

EP. 3: Sequencing of Therapies for Early-Stage Breast Cancer

EP. 4: TAILORx Trial

EP. 5: Early-Stage Breast Cancer: Gene Expression Profiling

EP. 6: Impact of COVID-19: Management of Early-Stage Breast Cancer

A review of the TAILORx trial using the Oncotype DX assay to inform decisions in the adjuvant setting for treatment of HR+, HER2- breast cancer.